Health Plans Defend Renewed Biogen MS Drug Scheme Suit
By Lauraann Wood · November 26, 2025, 8:29 PM EST
Health plans claiming Biogen Inc. illegally stifled competition for its multiple sclerosis drug Tecfidera have said an Illinois federal judge should let their latest complaint proceed to discovery because it fixes...
To view the full article, register now.